annual CFF:
$250.78M+$157.91M(+170.04%)Summary
- As of today (May 29, 2025), VRNA annual cash flow from financing activities is $250.78 million, with the most recent change of +$157.91 million (+170.04%) on December 31, 2024.
- During the last 3 years, VRNA annual CFF has risen by +$256.90 million (+4199.71%).
- VRNA annual CFF is now at all-time high.
Performance
VRNA Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$13.46M-$80.70M(-85.71%)Summary
- As of today (May 29, 2025), VRNA quarterly cash flow from financing activities is $13.46 million, with the most recent change of -$80.70 million (-85.71%) on March 31, 2025.
- Over the past year, VRNA quarterly CFF has increased by +$16.58 million (+530.90%).
- VRNA quarterly CFF is now -92.86% below its all-time high of $188.39 million, reached on September 30, 2020.
Performance
VRNA quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$267.36M+$16.58M(+6.61%)Summary
- As of today (May 29, 2025), VRNA TTM cash flow from financing activities is $267.36 million, with the most recent change of +$16.58 million (+6.61%) on March 31, 2025.
- Over the past year, VRNA TTM CFF has increased by +$246.30 million (+1169.45%).
- VRNA TTM CFF is now at all-time high.
Performance
VRNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VRNA Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +170.0% | +530.9% | +1169.5% |
| 3 y3 years | +4199.7% | +1953.6% | +4007.0% |
| 5 y5 years | +100.0% | +100.0% | +10000.0% |
VRNA Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4199.7% | -91.9% | +289.9% | at high | +4007.0% |
| 5 y | 5-year | at high | +4199.7% | -92.9% | +289.9% | at high | +4007.0% |
| alltime | all time | at high | +4199.7% | -92.9% | +289.9% | at high | +4007.0% |
VRNA Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $13.46M(-85.7%) | $267.36M(+6.6%) |
| Dec 2024 | $250.78M(+170.0%) | $94.16M(-1428.6%) | $250.78M(+38.8%) |
| Sep 2024 | - | -$7.09M(-104.2%) | $180.63M(-3.8%) |
| Jun 2024 | - | $166.83M(-5442.0%) | $187.77M(+791.5%) |
| Mar 2024 | - | -$3.12M(-113.0%) | $21.06M(-77.3%) |
| Dec 2023 | $92.87M(-34.1%) | $24.01M(>+9900.0%) | $92.87M(+29.9%) |
| Sep 2023 | - | $48.00K(-61.3%) | $71.47M(-66.1%) |
| Jun 2023 | - | $124.00K(-99.8%) | $211.04M(+0.4%) |
| Mar 2023 | - | $68.69M(+2527.6%) | $210.23M(+49.3%) |
| Dec 2022 | $140.82M(-2402.1%) | $2.61M(-98.1%) | $140.82M(+2.6%) |
| Sep 2022 | - | $139.62M(<-9900.0%) | $137.30M(-3422.1%) |
| Jun 2022 | - | -$689.00K(-5.1%) | -$4.13M(-39.6%) |
| Mar 2022 | - | -$726.00K(-19.4%) | -$6.84M(+11.9%) |
| Dec 2021 | -$6.12M(-103.2%) | -$901.00K(-50.4%) | -$6.12M(+383.2%) |
| Sep 2021 | - | -$1.82M(-46.5%) | -$1.27M(-100.7%) |
| Jun 2021 | - | -$3.40M(<-9900.0%) | $188.94M(-1.8%) |
| Mar 2021 | - | $0.00(-100.0%) | $192.34M(0.0%) |
| Dec 2020 | $192.34M(>+9900.0%) | $3.95M(-97.9%) | $192.34M(+1.9%) |
| Sep 2020 | - | $188.39M(>+9900.0%) | $188.76M(>+9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | $212.90K(+94.3%) |
| Mar 2020 | - | $0.00(-100.0%) | $109.60K(>+9900.0%) |
| Dec 2019 | $0.00 | $372.00K(-333.8%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$159.10K(+54.0%) | -$372.00K(+74.7%) |
| Jun 2019 | - | -$103.30K(-5.7%) | -$212.90K(+94.3%) |
| Mar 2019 | - | -$109.60K(<-9900.0%) | -$109.60K(<-9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $0.00(0.0%) | $742.00K(-73.7%) |
| Jun 2018 | - | $0.00(0.0%) | $2.82M(-96.8%) |
| Mar 2018 | - | $0.00(-100.0%) | $86.79M(+1.5%) |
| Dec 2017 | $85.47M(+68.1%) | $742.00K(-64.3%) | $85.47M(+0.9%) |
| Sep 2017 | - | $2.08M(-97.5%) | $84.73M(+2.5%) |
| Jun 2017 | - | $83.97M(-6455.3%) | $82.65M(-6355.3%) |
| Mar 2017 | - | -$1.32M | -$1.32M |
| Dec 2016 | $50.84M(>+9900.0%) | - | - |
| Dec 2015 | $0.00(-100.0%) | - | - |
| Dec 2014 | $20.39M(+586.2%) | - | - |
| Dec 2013 | $2.97M(+81.3%) | - | - |
| Dec 2012 | $1.64M(-50.2%) | - | - |
| Dec 2011 | $3.29M(+144.2%) | - | - |
| Dec 2010 | $1.35M(-58.5%) | - | - |
| Dec 2009 | $3.25M(-8.9%) | - | - |
| Dec 2008 | $3.57M(+6.6%) | - | - |
| Dec 2006 | $3.35M(+104.2%) | - | - |
| Dec 2005 | $1.64M | - | - |
FAQ
- What is Verona Pharma annual cash flow from financing activities?
- What is the all time high annual CFF for Verona Pharma?
- What is Verona Pharma annual CFF year-on-year change?
- What is Verona Pharma quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Verona Pharma?
- What is Verona Pharma quarterly CFF year-on-year change?
- What is Verona Pharma TTM cash flow from financing activities?
- What is the all time high TTM CFF for Verona Pharma?
- What is Verona Pharma TTM CFF year-on-year change?
What is Verona Pharma annual cash flow from financing activities?
The current annual CFF of VRNA is $250.78M
What is the all time high annual CFF for Verona Pharma?
Verona Pharma all-time high annual cash flow from financing activities is $250.78M
What is Verona Pharma annual CFF year-on-year change?
Over the past year, VRNA annual cash flow from financing activities has changed by +$157.91M (+170.04%)
What is Verona Pharma quarterly cash flow from financing activities?
The current quarterly CFF of VRNA is $13.46M
What is the all time high quarterly CFF for Verona Pharma?
Verona Pharma all-time high quarterly cash flow from financing activities is $188.39M
What is Verona Pharma quarterly CFF year-on-year change?
Over the past year, VRNA quarterly cash flow from financing activities has changed by +$16.58M (+530.90%)
What is Verona Pharma TTM cash flow from financing activities?
The current TTM CFF of VRNA is $267.36M
What is the all time high TTM CFF for Verona Pharma?
Verona Pharma all-time high TTM cash flow from financing activities is $267.36M
What is Verona Pharma TTM CFF year-on-year change?
Over the past year, VRNA TTM cash flow from financing activities has changed by +$246.30M (+1169.45%)